These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36239661)
1. Semaphorin 4A as a Potential Biomarker for Diagnosis of Systemic Lupus Erythematosus. He R; Tan X; Xiang J; Zhu J; Jiang Y; Liu W; Li Y; Guo B; Xing Y Immunol Invest; 2023 Jan; 52(1):104-116. PubMed ID: 36239661 [TBL] [Abstract][Full Text] [Related]
2. T-cell specific upregulation of Sema4A as risk factor for autoimmunity in systemic lupus erythematosus and rheumatoid arthritis. Cavalcanti CAJ; Germoglio V; de Azevêdo Silva J; Glesse N; Vianna P; Cechim G; Monticielo OA; Xavier RM; Brenol JCT; Brenol CV; Fragoso TS; Barbosa AD; Duarte ÂLBP; Oliveira RDR; Louzada-Júnior P; Donadi EA; Chies JAB; Crovella S; Sandrin-Garcia P Autoimmunity; 2020 Mar; 53(2):65-70. PubMed ID: 31876207 [TBL] [Abstract][Full Text] [Related]
3. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus]. Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195 [No Abstract] [Full Text] [Related]
4. Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity. Gravand A; Alesaeidi S; Khoshbakht S; Saghaei M; Kenarangi T; Mosallaei M; Soosanabadi M Clin Rheumatol; 2023 Dec; 42(12):3387-3395. PubMed ID: 37597101 [TBL] [Abstract][Full Text] [Related]
5. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus. Wang P; Mao YM; Liu LN; Zhao CN; Li XM; Pan HF Immunol Invest; 2020 Feb; 49(1-2):69-80. PubMed ID: 31412748 [TBL] [Abstract][Full Text] [Related]
6. Circular RNAs hsa_circ_0000479 in peripheral blood mononuclear cells as novel biomarkers for systemic lupus erythematosus. Luo Q; Zhang L; Fang L; Fu B; Guo Y; Huang Z; Li J Autoimmunity; 2020 May; 53(3):167-176. PubMed ID: 32093518 [TBL] [Abstract][Full Text] [Related]
7. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990 [TBL] [Abstract][Full Text] [Related]
8. Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement. Luo Q; Zhang L; Xiong L; Fu B; Guo Y; Huang Z; Li J Clin Exp Rheumatol; 2020; 38(5):822-833. PubMed ID: 32940208 [TBL] [Abstract][Full Text] [Related]
9. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. Wang L; Song G; Zheng Y; Tan W; Pan J; Zhao Y; Chang X Arthritis Res Ther; 2015 Aug; 17(1):227. PubMed ID: 26303122 [TBL] [Abstract][Full Text] [Related]
10. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346 [TBL] [Abstract][Full Text] [Related]
11. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787 [TBL] [Abstract][Full Text] [Related]
12. Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis. Avouac J; Pezet S; Vandebeuque E; Orvain C; Gonzalez V; Marin G; Mouterde G; Daïen C; Allanore Y Arthritis Rheumatol; 2021 Sep; 73(9):1579-1588. PubMed ID: 33605067 [TBL] [Abstract][Full Text] [Related]
13. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Cole S; Walsh A; Yin X; Wechalekar MD; Smith MD; Proudman SM; Veale DJ; Fearon U; Pitzalis C; Humby F; Bombardieri M; Axel A; Adams H; Chiu C; Sharp M; Alvarez J; Anderson I; Madakamutil L; Nagpal S; Guo Y Arthritis Res Ther; 2018 May; 20(1):85. PubMed ID: 29720240 [TBL] [Abstract][Full Text] [Related]
14. ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus. Yolbas S; Kara M; Kalayci M; Yildirim A; Gundogdu B; Aydin S; Koca SS Adv Clin Exp Med; 2018 Dec; 27(12):1637-1641. PubMed ID: 30141839 [TBL] [Abstract][Full Text] [Related]
15. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria. Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic significance of anti-collectin 11 in systemic lupus erythematosus]. Deng XL; Zhong LJ; Sun L; Li CH; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):982-986. PubMed ID: 27987501 [TBL] [Abstract][Full Text] [Related]
17. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation. Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723 [TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus. Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926 [TBL] [Abstract][Full Text] [Related]
19. Serum phosphatidylserine-specific phospholipase A Sawada T; Kurano M; Shirai H; Iwasaki Y; Tahara K; Hayashi H; Igarashi K; Fujio K; Aoki J; Yatomi Y Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739 [TBL] [Abstract][Full Text] [Related]
20. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis. Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]